Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise INCHEON, South Korea, Jan. 8, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization...
Read More Details
Finally We wish PressBee provided you with enough information of ( Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development )
Also on site :